Search research articles
Contact Us
Filters
Showing results (51-60 of 55) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 55 results.
Laryngoscope Investigative Otolaryngology
|
August 24, 2022
Treatment failure patterns are similar between p16- and p16+ oropharyngeal squamous cell carcinomas
Chelsea S Hamill, Richard Grant Muller, Kate Clancy, et al.
Oral Oncology
|
April 18, 2022
Impact of AJCC 8th edition staging system and definitive treatment choice on the prognosis of complete responders with p16+ and p16- oropharyngeal squamous cell carcinomas
R Grant Muller, Chelsea S Hamill, Brandon Vu, et al.
Cancers
|
October 13, 2021
Impact of p16 Status and Anatomical Site in Anti-PD-1 Immunotherapy-Treated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Patients
Kate Clancy, Chelsea S Hamill, W Quinn O'Neill, et al.
Frontiers in Oncology
|
December 13, 2021
Multi-Institutional Study Validates Safety of Intraoperative Cesium-131 Brachytherapy for Treatment of Recurrent Head and Neck Cancer
Adam Luginbuhl, Alyssa Calder, David Kutler, et al.
Head & Neck
|
June 10, 2014
Randomized phase III study of 2 cisplatin-based chemoradiation regimens in locally advanced head and neck squamous cell carcinoma: impact of changing disease epidemiology on contemporary trial design
Cristina P Rodriguez, David J Adelstein, Lisa A Rybicki, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 55) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 55 results.
Laryngoscope Investigative Otolaryngology
|
August 24, 2022
Treatment failure patterns are similar between p16- and p16+ oropharyngeal squamous cell carcinomas
Chelsea S Hamill, Richard Grant Muller, Kate Clancy, et al.
Oral Oncology
|
April 18, 2022
Impact of AJCC 8th edition staging system and definitive treatment choice on the prognosis of complete responders with p16+ and p16- oropharyngeal squamous cell carcinomas
R Grant Muller, Chelsea S Hamill, Brandon Vu, et al.
Cancers
|
October 13, 2021
Impact of p16 Status and Anatomical Site in Anti-PD-1 Immunotherapy-Treated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Patients
Kate Clancy, Chelsea S Hamill, W Quinn O'Neill, et al.
Frontiers in Oncology
|
December 13, 2021
Multi-Institutional Study Validates Safety of Intraoperative Cesium-131 Brachytherapy for Treatment of Recurrent Head and Neck Cancer
Adam Luginbuhl, Alyssa Calder, David Kutler, et al.
Head & Neck
|
June 10, 2014
Randomized phase III study of 2 cisplatin-based chemoradiation regimens in locally advanced head and neck squamous cell carcinoma: impact of changing disease epidemiology on contemporary trial design
Cristina P Rodriguez, David J Adelstein, Lisa A Rybicki, et al.
Page
of 6